Literature DB >> 6895332

Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles.

Y J Kao, R L Juliano.   

Abstract

Large unilamellar liposomes (also called reversed phase vesicles or REVs) composed of DPPC and cholesterol are cleared from the circulation of the rat by a process which closely resembles the clearance of colloidal particles by the reticuloendothelial system. Thus, increasing the total amount of REVs administered by giving a loading dose of unlabelled REVs slows the clearance of a test dose of radioactively labelled REVs. This resembles the reticuloendothelial 'blockade' induced by large doses of colloids. Administration of other types of particles known to induce reticuloendothelial blockade, such as latex beads and xenogeneic red cells, also slows the clearance of radioactively labelled REVs. Administration of small unilamellar liposomes (SUVs) can also cause blockade of REV clearance, but the onset of blockade is delayed until a substantial fraction of the SUVs have been removed from the circulation. Blockade caused by the administration of large doses of REVs seems to result from a direct action on reticuloendothelial cells rather than from depletion of opsonic factors in the blood. Partial blockade of REV clearance produces a modest alteration of the tissue distribution of REVs, with enhanced uptake in the lungs. These results suggest that both REVs and SUVs are taken up by the reticuloendothelial system via a process which closely resembles the clearance of other types of colloids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895332     DOI: 10.1016/0304-4165(81)90259-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

1.  Monitoring Tumor Response after Liposomal Doxorubicin in Combination with Liposomal Vinorelbine Treatment Using 3'-Deoxy-3'-[18F]Fluorothymidine PET.

Authors:  Chun-Yi Wu; Jo-Hsin Tang; Pei-Chia Chan; Jia-Je Li; Ming-Hsien Lin; Chih-Chieh Shen; Ren-Shyan Liu; Hsin-Ell Wang
Journal:  Mol Imaging Biol       Date:  2017-06       Impact factor: 3.488

2.  ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.

Authors:  Chi-Ling Chiang; Swagata Goswami; Frank W Frissora; Zhiliang Xie; Pearlly S Yan; Ralf Bundschuh; Logan A Walker; Xiaomeng Huang; Rajeswaran Mani; Xiaokui M Mo; Sivasubramanian Baskar; Christoph Rader; Mitch A Phelps; Guido Marcucci; John C Byrd; L James Lee; Natarajan Muthusamy
Journal:  Blood       Date:  2019-05-31       Impact factor: 22.113

3.  Low density lipoprotein receptor-independent hepatic uptake of a synthetic, cholesterol-scavenging lipoprotein: implications for the treatment of receptor-deficient atherosclerosis.

Authors:  K J Williams; S Vallabhajosula; I U Rahman; T M Donnelly; T S Parker; M Weinrauch; S J Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Liposomal simvastatin attenuates neointimal hyperplasia in rats.

Authors:  Eyal Afergan; Meital Ben David; Hila Epstein; Nickolay Koroukhov; Dalia Gilhar; Keren Rohekar; Haim D Danenberg; Gershon Golomb
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

5.  The systemic activation of macrophages by liposomes containing immunomodulators.

Authors:  R Nayar; I J Fidler
Journal:  Springer Semin Immunopathol       Date:  1985

Review 6.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

7.  Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase.

Authors:  J F Turrens; J D Crapo; B A Freeman
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites.

Authors:  K Mehta; R L Juliano; G Lopez-Berestein
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

9.  Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine.

Authors:  G Lopez-Berestein; L Milas; N Hunter; K Mehta; E M Hersh; C G Kurahara; M Vandupas; D A Eppstein
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

10.  Suppression of liver uptake of liposomes by dextran sulfate 500.

Authors:  K R Patel; M P Li; J D Baldeschwieler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.